These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 36924839)

  • 61. Neutralizing antibodies to Omicron after the fourth SARS-CoV-2 mRNA vaccine dose in immunocompromised patients highlight the need of additional boosters.
    Rescigno M; Agrati C; Salvarani C; Giannarelli D; Costantini M; Mantovani A; Massafra R; Zinzani PL; Morrone A; Notari S; Matusali G; Pinter GL; Uccelli A; Ciliberto G; Baldanti F; Locatelli F; Silvestris N; Sinno V; Turola E; Lupo-Stanghellini MT; Apolone G;
    Front Immunol; 2023; 14():1104124. PubMed ID: 36776853
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Sequence analysis of the emerging SARS-CoV-2 variant Omicron in South Africa.
    Wang L; Cheng G
    J Med Virol; 2022 Apr; 94(4):1728-1733. PubMed ID: 34897752
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Sotrovimab Resistance and Viral Persistence After Treatment of Immunocompromised Patients Infected With the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant.
    Huygens S; Oude Munnink B; Gharbharan A; Koopmans M; Rijnders B
    Clin Infect Dis; 2023 Feb; 76(3):e507-e509. PubMed ID: 35867699
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021-March, 2022: a national, observational, test-negative, case-control study.
    Powell AA; Kirsebom F; Stowe J; Ramsay ME; Lopez-Bernal J; Andrews N; Ladhani SN
    Lancet Infect Dis; 2023 Apr; 23(4):435-444. PubMed ID: 36436536
    [TBL] [Abstract][Full Text] [Related]  

  • 65. SARS-CoV-2 B.1.1.7 lineage rapidly spreads and replaces R.1 lineage in Japan: Serial and stationary observation in a community.
    Hirotsu Y; Omata M
    Infect Genet Evol; 2021 Nov; 95():105088. PubMed ID: 34560289
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The Rise and Fall of SARS-CoV-2 Variants and Ongoing Diversification of Omicron.
    Wiegand T; Nemudryi A; Nemudraia A; McVey A; Little A; Taylor DN; Walk ST; Wiedenheft B
    Viruses; 2022 Sep; 14(9):. PubMed ID: 36146815
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Protocol for studying co-infection between SARS-CoV-2 and Staphylococcus aureus in vitro.
    Goncheva MI; Heinrichs DE
    STAR Protoc; 2023 Sep; 4(3):102411. PubMed ID: 37393614
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Elevated HIV Viral Load is Associated with Higher Recombination Rate In Vivo.
    Romero EV; Feder AF
    Mol Biol Evol; 2024 Jan; 41(1):. PubMed ID: 38197289
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Performance of amplicon and capture based next-generation sequencing approaches for the epidemiological surveillance of Omicron SARS-CoV-2 and other variants of concern.
    Daviña-Núñez C; Pérez S; Cabrera-Alvargonzález JJ; Rincón-Quintero A; Treinta-Álvarez A; Godoy-Diz M; Suárez-Luque S; Regueiro-García B
    PLoS One; 2024; 19(4):e0289188. PubMed ID: 38683803
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Stuck in pandemic uncertainty: a review of the persistent effects of COVID-19 infection in immune-deficient people.
    Manuelpillai B; Zendt M; Chang-Rabley E; Ricotta EE
    Clin Microbiol Infect; 2024 Aug; 30(8):1007-1011. PubMed ID: 38552795
    [TBL] [Abstract][Full Text] [Related]  

  • 71. VIPERA: Viral Intra-Patient Evolution Reporting and Analysis.
    Álvarez-Herrera M; Sevilla J; Ruiz-Rodriguez P; Vergara A; Vila J; Cano-Jiménez P; González-Candelas F; Comas I; Coscollá M
    Virus Evol; 2024; 10(1):veae018. PubMed ID: 38510921
    [TBL] [Abstract][Full Text] [Related]  

  • 72. "Nano COVID-19": Nanopore sequencing of spike gene to identify SARS-CoV-2 variants of concern.
    Nimsamer P; Sawaswong V; Klomkliew P; Kaewsapsak P; Puenpa J; Poovorawan Y; Payungporn S
    Exp Biol Med (Maywood); 2023 Oct; 248(20):1841-1849. PubMed ID: 37702217
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Evidence for SARS-CoV-2 Delta and Omicron co-infections and recombination.
    Bolze A; Basler T; White S; Dei Rossi A; Wyman D; Dai H; Roychoudhury P; Greninger AL; Hayashibara K; Beatty M; Shah S; Stous S; McCrone JT; Kil E; Cassens T; Tsan K; Nguyen J; Ramirez J; Carter S; Cirulli ET; Schiabor Barrett K; Washington NL; Belda-Ferre P; Jacobs S; Sandoval E; Becker D; Lu JT; Isaksson M; Lee W; Luo S
    Med; 2022 Dec; 3(12):848-859.e4. PubMed ID: 36332633
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Recombinant SARS-CoV-2 Delta/Omicron BA.5 emerging in an immunocompromised long-term infected COVID-19 patient.
    Garcia I; Bråte J; Fossum E; Rohringer A; Moen LV; Hungnes O; Fjære O; Zaragkoulias K; Bragstad K
    Sci Rep; 2024 Oct; 14(1):25790. PubMed ID: 39468221
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Molecular evolution of SARS-CoV-2 from December 2019 to August 2022.
    Wolf JM; Wolf LM; Bello GL; Maccari JG; Nasi LA
    J Med Virol; 2023 Jan; 95(1):e28366. PubMed ID: 36458547
    [TBL] [Abstract][Full Text] [Related]  

  • 76. SARS-CoV-2 coinfection in immunocompromised host leads to the generation of recombinant strain.
    Zannoli S; Brandolini M; Marino MM; Denicolò A; Mancini A; Taddei F; Arfilli V; Manera M; Gatti G; Battisti A; Grumiro L; Scalcione A; Dirani G; Sambri V
    Int J Infect Dis; 2023 Jun; 131():65-70. PubMed ID: 36924839
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Resurgence of SARS-CoV-2 Delta after Omicron variant superinfection in an immunocompromised pediatric patient.
    Alisoltani A; Simons LM; Agnes MFR; Heald-Sargent TA; Muller WJ; Kociolek LK; Hultquist JF; Lorenzo-Redondo R; Ozer EA
    Virol J; 2023 Oct; 20(1):246. PubMed ID: 37891657
    [TBL] [Abstract][Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.